PECULIARITIES OF CHANGES IN POLYAMINS LEVELS IN THE DYNAMICS OF PARENTAL AND CISPLATIN-RESISTANT GUÉRIN’S CARCINOMA GROWTH
DOI:
https://doi.org/10.32471/oncology.2663-7928.t-23-3-2021-g.9686Keywords:
Guérin’s carcinoma, peripheral blood, putrescine, resistance, spermidine, spermine, tumor tissueAbstract
The results of many studies have shown that intensification of polyamine synthesis (PAs) and its accumulation in tumor tissues as well as in blood, urine and spinal-cerebral fluid is a characteristic of human and animals’ malignant tumors. There are some evidence that effective cytostatic treatment is accompanied by a decrease in PA content in tumor tissue and in the biological fluids of experimental animals and cancer patients. Meanwhile, the assumption that detection of PA in biological fluids can be used in monitoring the treatment process remains to be elucidated. Aim: to investigate the levels of PAs in the tumor tissue of parental and cisplatin-resistant substrains of Guérin’s carcinoma as well as in the peripheral blood of tumor-bearing rats in the dynamics of the tumor growth. Object and methods: Wistar rats, parental and cisplatin-resistant substrains of Guérin’s carcinoma, peripheral blood of tumor-bearing rats. PA (spermine (Spn), spermidine (Spd), acetylated form of spermidine (Acetyl-Spd) and putrescine (Put)) content in the tumor tissue and peripheral blood was determined by high pressure liquid chromatography. The statistical analysis of the results was performed according to generally accepted methods of variation statistics. Results: as parental Guérin’s carcinoma progresses (exponential phase), the level of Spd, Acetyl-Spd, Spn in tumors tissues as well as Spd/Spm ratio were increasing while the level of Put was declining. Later on, the levels of all tested PA fractions decreased. In the exponential phase of cisplatin-resistant carcinoma growth, the levels of Spd, Put and the Spd/Spn ratio were increasing, while the levels of Spn and Acetyl-Spd were decreasing. As compared to the corresponding data of the parental strain of the Guérin’s carcinoma, the level of Put in tissue of cisplatin-resistant carcinoma remained higher in all periods of the study, while the levels of Spd and Spn during the exponential phase were lower. In both groups of tumor-bearing animals, changes in PA levels in the peripheral blood correlated with their levels in tumor tissue. Conclusions: there was shown, that cisplatin-resistant substrain of Guérin’s carcinoma is characterized by changes in PA metabolism compared to the parental strain. The obtained data on the peculiarities of PA levels dynamics in tumor tissue and peripheral blood of experimental animals depending on the sensitivity of tumors to cytostatic drug can be further used in clinical settings to monitor the effects of chemotherapy on the tumor process.
References
Igarashi K, Kashiwagi K. The functional role of polyamines in eukaryotic cells. Int J Biochem Cell Biol 2019; 107: 104–15.
Berdinsky NK, Zaletok SP. Polyamines and tumor growth. Kyiv: Naukova dumka. Наукова думка, Київ, 1987: 1–141.
Kabir A, Suresh Kumar G. Targeting double-stranded RNA with spermine, 1-naphthylacetyl spermine and spermidine: a comparative biophysical investigation. J Phys Chem B 2014; 118: 11050–64.
Pegg AE. Mammalian polyamine metabolism and function. IUBMB Life 2009; 61: 880-94.
Lightfoot HL, Hall J, Endogenous polyamine function — the RNA perspective. Nucleic Acids Res 2014; 42: 11275–90.
Medina MÁ, Urdiales JL, Rodríguez-Caso C, et al. Biogenic amines and polyamines: similar biochemistry for different physiological missions and biomedical applications. Crit Rev Biochem Mol Biol 2003; 38: 23–59.
Stewart МT, Dunston TT, Woster PM, Casero RA. Polyamine catabolism and oxidative damage. J Biol Chem 2018; 293: 18736–45.
Zaletok JV, Berdyn NC, Tarutinov VI, et al. Study of indicators of polyamine metabolism in tumors and physiological fluids in patients with breast tumors. Oncology 2000; 2 (4): 250-2 (in Ukrainian).
Zaletok JV, Klenov OO, Gogol JV, et al. Blood and urine polyamines as new diagnostic markers of prostate cancer. Oncology 2019; 21 (3): 219–24 (in Ukrainian).
Murray-Stewart TR, Woster PM & Casero RA Jr. Targeting polyamine metabolism for cancer therapy and prevention. Biochem J 2016; 473: 2937–53.
Park MH, Igarashi K. Polyamines and their metabolites as diagnostic markers of human diseases. Biomol Ther 2013; 21 (1): 1–9.
Zaletok SP. Polyamines are markers of malignant growth and a target for anticancer therapy. Kyiv 2007. 37 с (in Ukrainian).
Yurchenko OV, Todor IN, Tryndyak VP, et al. Resistance of Guerin’s carcinoma cells to cisplatine: biochemical and morphological aspects. Exp. Oncol 2003; 25 (1): 64–68.
Gerbaut L. Determination of erythrocytic polyamines by reversed-phase liquid chromatography. Clin Chem. 1991; 37 (12): 2117–20.